Evaluation of effectiveness and analysis of goal-directed blood transfusion in peri-operation of major orthopedic surgery in elderly patients
Authors:
Open Access
- 26 November 2012
- journal article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 5 (2) , 511-516
Abstract
Through the establishment of blood transfusion-effectiveness assessment criteria, we aimed to evaluate and analyze the effectiveness of peri-operative red blood cell transfusion for major orthopedics in elderly patients. Male and female patients (n=106) with American Society of Anesthesiologists (ASA) stage II-III, aged 60-80 years and scheduled for elective orthopedic surgery were randomly divided into 2 groups: group I (n=52), received the traditional method of red blood cell transfusion and group II (n=54) received hemoglobin (Hb) and hematocrit (Hct) goal-directed red blood cell (RBC) transfusion. We compared the changes in Hb, Hct, RBC, platelet (PLT), prothrombin time (PT), activated partial thromboplastin time (APTT), alveolar-arterial oxygen partial pressure [P(A-a)O2], oxygenation index (OI) and Vigileo monitoring indicators following RBC composition transfusion before and after surgery. We also monitored wound healing time, number of hospitalization days and intensive care unit (ICU) transfer rate. Blood transfusion-effectiveness assessment criteria were used to evaluate the efficacy and safety of Hb and Hct goal-directed RBC transfusion in orthopedic elderly patients. The two groups demonstrated an efficiency of 61.5 and 72.2%, respectively (P>0.05). The P(A-a)O2 and OI in the two groups were not significantly different (P>0.05). Compared with the traditional RBC transfusion group, the Hb and Hct goal-directed RBC transfusion group presented increased RBC, Hb and Hct, as well as decreased PT and APTT and shorter wound healing time. The number of days of hospitalization and ICU transfer rate also decreased (P Introduction Blood protection in major orthopedic surgery has become a focus of attention and research, particularly with prolonged life expectancy, the development of orthopedic surgery technology and the constantly enhanced blood conservation awareness. In major orthopedic surgery, the proportion of elderly patients increases each year (1). Due to the decline in organ function, elderly patients have a significantly increased postoperative infection rate and mortality compared with young and middle-aged patients under the same condition of blood loss (2,3). Significant blood loss is one cause of peri-operative complications in elderly patients (4,5). A method to evaluate the effectiveness of blood transfusions is a current key issue. However, in all peri-operative blood transfusion guides, only the circumstances in which blood transfusions are needed is mentioned, not how to correctly and reasonably give a blood transfusion to elicit the best effect. Therefore, an evaluation system of blood transfusion effectiveness is needed. In this study, we compared the traditional red blood cell (RBC) trans-fusion method to the hemoglobin (Hb) and hematocrit (Hct) goal-directed RBC transfusion method to objectively evaluate the effectiveness of blood transfusion in peri-operation of major surgery in elderly patients, thereby providing theoretical basis to establish reasonable and individual clinical blood conservation strategies. Materials and methods Subjects This study was approved by the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University and patients provided informed consent. A total of 106 male and female patients were included from orthopedic elective surgeries. Patients were classified as American Society of Anesthesiologists (ASA) stage II–III, according to their systemic conditions. The average age was 70±6 years and the average weight was 68±13 kg. Eight patients had a history of more than two blood transfusions. Patients were randomly divided into the control group (n=52) and the experimental group (n=54) using the envelope method. The control group (group 1) received the traditional RBC transfusion method and the experimental group (group 2) received the Hb and Hct goal-directed RBC transfusion method. The inclusion criteria were as follows: according to the World Health Organisation (WHO) criteria, patients were aged 60–80 years, with cardiac function ≤ level II and did not have a preoperative history of mental or neurological disease or transfusion allergy. The expected intraoperative blood loss was >20% of the total blood volume. Patients were required to be in accordance with the transfusion indications of RBC suspension stipulated in the Clinical transfusion technical specifications (2000) by the Chinese Ministry of Health. The exclusion criteria were as follows: above ASA level III, temperature >38°C, a history of coronary heart disease or diabetes, ejection fraction (EF) Scores Hb Hct PT APTT OI (mmHg) 5 Normal Normal Normal Normal >300 +1 Increased 1 g/dl Increased 1% −1 sec −3 sec 300–400 +2 Increased 2 g/dl Increased 2% −2 sec −6 sec >400 [i] Hb, hemoglobin; Hct, hematocrit; PT, prothrombin time; APTT, activated partial thromboplastin time; OI, oxygenation index. Table II. Blood transfusion effectiveness score. Table II. Blood transfusion effectiveness score. Scores Transfusion complications Wound healing time (days) Length of stay (days) ICU transfer rate 5 None None −1 1 item 12–15 10–12 1 time −2 2 items >15 >12 ≥2 times [i] ICU, intensive care unit. The standard for evaluation of blood transfusion effectiveness was: 8, valid and >10, highly effective (Tables I and II). Monitoring indicators The general data of patients were recorded. Patients were given radial arterial blood gas analysis using a portable blood gas analyzer (i-STAT 1, Abbott Laboratories, IL, USA) after entering the operating room and Hb, Hct and RBC were recorded. The heart rate (HR), blood pressure (BP), temperature (T) and SpO2 were recorded with a S/5 Avance anesthesia machine (Datex Ohmeda, Finland) and a BeneviewT6 patient monitor (Shenzhen Mindray Bio-Medical Electronics Co., Ltd., China). At the same time, the cardiac index (CI), stroke volume index (SVI) and the corresponding systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP) and heart rate (HR) were monitored with a Flotrac sensor and Vigileo monitor (software version 1.07, Edwards Lifesciences, Irvine, CA, USA) to calculate the surrounding vascular resistance (SVR = MAP x 80/CO) as a basic value (T0). Thereafter, the radial arterial blood gas analysis was performed at 12 h (T1), 24 h (T2) and 48 h (T3) after blood transfusion. At the same time, surgery time (from skin incision to the end of surgery), adverse transfusion reactions, complication rate, wound healing time, length of stay, ICU transfer rate and intraoperative RBC transfer volumes were recorded. The main monitoring indicators included Hb and Hct and the secondary monitoring indicators included APTT, PT, P(A-a)O2, OI and Vigileo monitored indicators. Increased P(A-a)O2 caused by pathological factors, including anatomical shunt, ventilation/perfusion imbalance and impeded diffusion of alveolar-capillary barriers was ruled out (8). The computational formula for P(A-a)O2 was as follows: P(A-a)O2 = [(atmospheric pressure - water vapor pressure x fraction of inspired oxygen (FiO2) - PaCO2/R] - PaO2, where the atmospheric pressure was 760 mmHg; the water vapor pressure, 47 mmHg and the respiratory quotient (R), 0.8. PaO2 and PaCO2 were measured by arterial blood gas. The formula for OI was as follows: OI = PaO2/FiO2. The outcome indicators that were monitored included adverse transfusion reactions and complication rate, wound healing time, length of stay and ICU transfer rate. Intraoperative blood loss was monitored and we calculated the observation time in the surgical field and communicated it with the surgeon to evaluate whether there was a significant amount of microvascular bleeding. Standard methods were taken to quantify the blood loss, including suction apparatus, gauze measurement and recycled blood volume. The formula for RBC suspension supplementation was: suspension supplementation of RBCs = [(predicted Hct - practical Hct) x 55 x weight]/0.60. Statistical analysis Patients were randomly divided into different groups by the envelope method. Data were analyzed by SPSS 13.0 statistical software (SPSS Inc., Chicago, IL, USA). Measurement data were expressed as mean ± standard deviation and enumeration data were determined by the univariate χ2 test. Comparison among groups was performed using a t-test and comparison within groups was performed using the variance analysis of repeated measurement data. P2 units (400 ml) and there were no intraoperative or postoperative transfusion-related allergic reactions or other related complications. There were 3 patients in group 1 that were transferred to the ICU for further treatment, with a transfer rate of 5.6% and an ICU detention time >24 h. There were no patients in group 2 that were transferred to the ICU. There was no statistical difference in age, height, weight, body surface area, cardiac function, duration of surgery, intraoperative transfusion volume of RBCs and length of stay between the two groups (P>0.05; Table III). Table III. Comparison of general data in patients. Table III. Comparison of general data in patients. Parameters Control group Experimental group P-value (χ2) Age (years) 69.2±5.9 70.1±5.8 0.974 Gender (n) Male 24 21 0.449 (0.572) Female 28 33 Height (cm) 174.2±7.8 174.3±4.9 0.941 Weight (kg) 80.1±18.1 76.2±10.1 0.370 Body surface area (m2) 2.05±0.26 2.00±0.15 0.452 Cardiac function Grade 1 12 15 0.890 (1.270) Grade 2 40 39 Duration of surgery (min) 166.0±66.7 194.6±82.4 0.051 Intraoperative red blood cells (unit) 2.4±1.2 2.7±1.4 0.300 Length of stay (days) 20.0±10.0 22.0±10.0 0.371 [i] The general conditions of patients in the experimental group were compared to those in the control group (P>0.05, Chi-square test). Data are presented as the mean ± standard deviation. Hb and Hct The comparison of parameters before and after blood transfusion in the two groups (Table II) revealed a significant difference in the Hb and Hct goal-directed RBC transfusion method (P>0.05). There was a statistical difference in RBC and PT before and after blood transfusion in the traditional method of RBC transfusion (P Parameters Group Before transfusion After transfusion P-value RBC (×1012/l) I 4.0±0.8 3.8±0.6 0.033 II 4.1±0.6 3.7±0.6 0.003 PLT (×109/l) I 209.4±79.1 213.1±75.8 0.746 II 181.1±60.1 166.5±59.0 0.002 Hct (%) I 38.9±5.1 38.0±5.0 0.287 II 37.5±6.3 34.5±5.6 0.006 Hb (g/l) I 118.7±19.7 113.4±17.0 0.161 II 126.0±21.1 119.3±22.5 0.007 PT (sec) I 7.1±2.0 8.0±2.0 0.032 II 8.3±3.0 7.2±3.0 0.024 APTT (sec) I 24.0±6.0 25.0±5.0 0.057 II 23.0±4.0 25.0±3.0 0.016 [i] Data are presented as the mean ± standard deviation. I, control group; II, experimental group; RBC, red blood cell; PLT, platelet; Hct, hematocrit; Hb, hemoglobin; PT, prothrombin time; APTT, activated partial thromboplastin time. P(A-a)O2 difference There were no significant differences in P(A-a)O2 and OI preoperatively (T0), at 12 h (T1), 24 h (T2) or 48 h (T3) after blood transfusion between the two groups (P>0.05; Table V), indicating that there is no difference in P(A-a)O2 change and OI before and after transfusion between the two groups. Table V. Alveolar-arterial oxygen partial pressure difference, oxygenation index and Vigileo monitored indicators at different time points in the two groups. Table V. Alveolar-arterial oxygen partial pressure difference, oxygenation index and Vigileo monitored indicators at different time points in the two groups. Monitoring indicators Time point Group I Group II P(A-a)O2 (mmHg) T0 21.3±5.2 20.9±4.9 T1 343.7±110.2 374.2±123.1 T2 418.5±95.3 417.4±137.3 T3 208.2±104.4 181.2±89.1 OI T0 379.4±32.3 400.0±23.7 T1 322.7±105.0 290.2±123.4 T2 239.2±95.1 229.6±166.8 T3 227.2±98.2 243.9±119.3 MAP (mmHg) T0 94±17 97±15 T1 81±19 80±13 T2 76±14 68±13 T3 81±10 80±7 HR (bpm) T0 75±13 67±21 T1 74±15 69±13 T2 78±14 67±13a T3 95±15 109±15a CI (l/min/m2) T0 3.1±0.7 3.6±0.8 T1 2.6±0.7 2.8±0.6 T2 2.8±0.6 2.5±0.4a T3 3.5±0.8 3.3±0.7 SVI (ml/beat/m2) T0 41±10 46±13 T1 37±10 41±7 T2 37±7 40±8 T3 38±6 33±6a SVR (dynes-sec/cm5) T0 1375±258 1243±318 T1 2525±535 2362±359 T2 1247±264 1258±340 T3 1058±288 1110±258 a P2, alveolar-arterial oxygen partial pressure; OI, oxygenation index; MAP, mean arterial pressure; HR, heart rate; CI, cardiac index; SVI, stroke volume index; SVR, surrounding vascular resistance. RBC transfusion Referring to the transfusion indications of RBC suspension stipulated in the Clinical transfusion technical specifications by the Chinese Ministry of Health, Hb should be 70–100 g/l, which is determined according to the degree of anemia, cardiopulmonary compensatory function, age and whether there is an increased metabolic rate, as well as other factors. In this study, compared to the traditional RBC transfusion method, we noted that in the Hb and Hct goal-directed RBC transfusion method, SpO2, body temperature and HR fluctuated when Hb 0.05). The reason for this may be related to normal or compensatory cardiopulmonary function in orthopedic elderly patients. At the same time, intraoperative RBC suspension volumes in 106 patients were all >2 units (400 ml) and there were no intraoperative and postoperative allergic reactions or other complications related to blood transfusion. The wound healing time and number of hospitalization days in group 1 were significantly higher than those in group 2. Three patients in group 1 were transferred into the ICU for further treatment, with a transfer rate of 5.6% and ICU detention time was >24 h. No patients were transferred into the ICU from group 2. This study aimed to establish a clinical scoring method to correctly evaluate the effectiveness of blood transfusion to achieve scientific, reasonable and effective blood transfusion. A number of studies have evaluated the effectiveness of RBC transfusion (10,11) with regard to whether Hb achieved the expected value after blood transfusion; however, there has been no evaluation of whether the clinical symptoms of the patients improved or monitoring of complications following blood transfusion (12). Low Hb in surgery patients may increase the incidence rate of postoperative complications (13,14), including the extension of postoperative recovery time (15,16) and an increase in postoperative infection susceptibility (17,18). Analysis of patients with postoperative Hb Leung JM and Dzankic S: Relative importance of preoperative health status versus intraoperative factors in predicting postoperative adverse outcomes in geriatric surgical patients. Am Geriatr Soc. 49:1080–1085. 2001. View Article : Google Scholar 2. Dunne JR, Malone D, Tracy JK, Gannon C and Napolitano LM: Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgey. J Surg Res. 102:237–244. 2002.PubMed/NCBI 3. Gruson KI, Aharonoff GB, Egol KA, Zuckerman JD and Koval KJ: The relationship between admission hemoglobin level and outcome after hip fracture. J Orthop Trauma. 16:39–44. 2002. View Article : Google Scholar : PubMed/NCBI 4. Hardy JF, de Moerloose P and Samama CM: Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth. 53:S40–S58. 2006. View Article : Google Scholar : PubMed/NCBI 5. Harvey MP, Greenfield TP, Sugrue ME and Rosenfeld D: Massive blood transfusion in a tertiary referral hospital. Clinical outcomes and haemostatic complications. Med J Aust. 163:356–359. 1995.PubMed/NCBI 6. Bohlius J, Schmidlin K, Brillant C, et al: Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet. 373:1532–1542. 2009. View Article : Google Scholar : PubMed/NCBI 7. Seghatchian J and Samama MM: Massive transfusion: an overview of the main characteristics and potential risks associated with substances used for correction of a coagulopathy. Transfus Apher Sci. 47:235–243. 2012. View Article : Google Scholar : PubMed/NCBI 8. Ronnie AR and Stephen MK: Assessment and management of the geriatric patient. Crit Care Med. 32:S92–S105. 2004. View Article : Google Scholar 9. Goodnough LT, Maniatis A and Earnshaw P: Management of preoperative anaemia in patients undergoing elective surgery. ISBT Sci Ser. 5:120–124. 2010. View Article : Google Scholar 10. Johansson PI, Ostrowski SR and Secher NH: Management of major blood loss: an update. Acta Anaesthesiol Scand. 54:1039–1049. 2010. View Article : Google Scholar : PubMed/NCBI 11. Lee A, Kerridge RK, Chui PT, Chiu CH and Gin T: Perioperative systems as a quality model of perioperative medicine and surgical care. Health Policy. 102:214–222. 2011. View Article : Google Scholar : PubMed/NCBI 12. Heddle NM, Arnold DM, Boye D, Webert KE, Resz I and Dumont LJ: Comparing the efficacy and safety of apheresis and whole blood-derived platelet transfusions: systematic review. Transfusion. 48:1447–1458. 2008. View Article : Google Scholar : PubMed/NCBI 13. Kuriyan M and Carson JL: Anemia and clinical outcomes. Anesthesiol Clin North Am. 23:315–325. vii2005. View Article : Google Scholar 14. Greenblatt DY, Rajamanickam V and Mell MW: Predictors of surgical site infection after open lower extremity revascularization. J Vasc Surg. 54:433–439. 2011. View Article : Google Scholar : PubMed/NCBI 15. Carson JL, Terrin ML and Jay M: Anemia and postoperative rehabilitation. Can J Anaesth. 50:S60–S64. 2003.PubMed/NCBI 16. Giles KA, Hamdan AD, Pomposelli FB, Wyers MC, Siracuse JJ and Schermerhorn ML: Body mass index: surgical site infections and mortality after lower extremity bypass from the National Surgical Quality Improvement Program 2005–2007. Ann Vasc Surg. 24:48–56. 2010.PubMed/NCBI 17. O’Keeffe SD, Davenport DL, Minion DJ, Sorial EE, Endean ED and Xenos ES: Blood transfusion is associated with increased morbidity and mortality after lower extremity revascularization. J Vasc Surg. 51:616–621. 2010.PubMed/NCBI 18. Lindholm PF, Annen K and Ramsey G: Approaches to minimize infection risk in blood banking and transfusion practice. Infect Disord Drug Targets. Aug 10–2010.(Epub ahead of print). 19. Cuenca J, Garcia-Erce JA, Martinez F, Cardona R, Pérez-Serrano L and Muñoz M: Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement. Int J Surg. 5:89–94. 2007. View Article : Google Scholar : PubMed/NCBI 20. Weiskopf RB, Kramer JH, Viele M, et al: Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology. 92:1646–1652. 2000. View Article : Google Scholar : PubMed/NCBI 21. Carson JL, Noveck H, Berlin JA and Gould SA: Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion. 42:812–818. 2002. View Article : Google Scholar : PubMed/NCBI 22. Ferraris VA, Davenport DL, Saha SP, Austin PC and Zwischenberger JB: Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg. 147:49–55. 2012. View Article : Google Scholar : PubMed/NCBI Related ArticlesKeywords
This publication has 23 references indexed in Scilit:
- Massive transfusion: An overview of the main characteristics and potential risks associated with substances used for correction of a coagulopathyTransfusion and Apheresis Science, 2012
- Perioperative Systems as a quality model of perioperative medicine and surgical careHealth Policy, 2011
- Predictors of surgical site infection after open lower extremity revascularizationJournal of Vascular Surgery, 2011
- Management of major blood loss: An updateActa Anaesthesiologica Scandinavica, 2010
- Management of preoperative anaemia in patients undergoing elective surgeryISBT Science Series, 2010
- Blood transfusion is associated with increased morbidity and mortality after lower extremity revascularizationJournal of Vascular Surgery, 2010
- Body Mass Index: Surgical Site Infections and Mortality after Lower Extremity Bypass from the National Surgical Quality Improvement Program 2005–2007Annals of Vascular Surgery, 2010
- Comparing the efficacy and safety of apheresis and whole blood–derived platelet transfusions: a systematic reviewTransfusion, 2008
- Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacementInternational Journal of Surgery, 2007
- Perioperative Anemia: An Independent Risk Factor for Infection, Mortality, and Resource Utilization in SurgeryJournal of Surgical Research, 2002